Development of small molecule non-covalent coronavirus 3CL protease inhibitors from DNA-encoded chemical library screening

Abstract Variants of SARS-CoV-2 have continued to emerge across the world and cause hundreds of deaths each week. Due to the limited efficacy of vaccines against SARS-CoV-2 and resistance to current therapies, additional anti-viral therapeutics with pan-coronavirus activity are of high interest. Her...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Hengrui Liu, Arie Zask, Farhad Forouhar, Sho Iketani, Alana Williams, Daniel R. Vaz, Dahlya Habashi, Karenna Choi, Samuel J. Resnick, Seo Jung Hong, David H. Lovett, Tian Bai, Alejandro Chavez, David D. Ho, Brent R. Stockwell
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2025-01-01
סדרה:	Nature Communications
גישה מקוונת:	https://doi.org/10.1038/s41467-024-55421-5
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!